Canada
Ottawa extends $500M-a-year rare-disease drug funding and bridges $1.2B for mental health care
At a Friday meeting of health ministers in Winnipeg, Ottawa locked in permanent funding for the rare-disease drugs strategy and a one-year extension for mental-health money — while the bigger Canada Health Transfer fight waits for the fall budget.